Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SCYNEXIS INC | Chief Executive Officer, Director | Common Stock | 272K | $816K | $3.00 | Apr 26, 2022 | Direct |
SCYNEXIS INC | Chief Executive Officer, Director | Common Stock Warrant | 75K | Apr 26, 2022 | Direct | ||
Aquestive Therapeutics, Inc. | Director | Stock Option (Right to Purchase) | 38K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AQST | Aquestive Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
AQST | Aquestive Therapeutics, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
AQST | Aquestive Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
SCYX | SCYNEXIS INC | Apr 26, 2022 | 2 | $225K | 4 | Apr 28, 2022 | Chief Executive Officer, Director |
SCYX | SCYNEXIS INC | Feb 4, 2022 | 2 | $0 | 4 | Feb 8, 2022 | Chief Executive Officer, Director |
AQST | Aquestive Therapeutics, Inc. | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |